These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
598 related articles for article (PubMed ID: 31562940)
1. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review. Raffi J; Suresh R; Botto N; Murase JE J Am Acad Dermatol; 2020 Jan; 82(1):132-138. PubMed ID: 31562940 [TBL] [Abstract][Full Text] [Related]
2. Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis. Stout M; Silverberg JI J Am Acad Dermatol; 2019 Jul; 81(1):157-162. PubMed ID: 30885752 [TBL] [Abstract][Full Text] [Related]
3. Characterization of Residual Facial Dermatitis during Dupilumab Therapy: A Retrospective Chart Review to Delineate the Potential Role of Expanded Series Patch Testing. Ashbaugh AG; Murase EM; Raffi J; Botto N; Murase JE Dermatitis; 2022 Jan-Feb 01; 33(1):51-61. PubMed ID: 35029349 [TBL] [Abstract][Full Text] [Related]
4. Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain. Docampo-Simón A; Sánchez-Pujol MJ; Pastor-Nieto MA; Giménez-Arnau A; Rodríguez-Serna M; Serra-Baldrich E; Miquel J; Sánchez-Pérez J; Sanz-Sánchez T; Zaragoza-Ninet V; Sánchez-Pedreño P; Carrascosa JM; Gatica-Ortega ME; Fernández-Redondo V; Córdoba-Guijarro S; González-Pérez R; Silvestre JF Dermatitis; 2023; 34(4):315-322. PubMed ID: 37001174 [No Abstract] [Full Text] [Related]
5. Dupilumab for Allergic Contact Dermatitis: An Overview of Its Use and Impact on Patch Testing. Johnson H; Adler BL; Yu J Cutis; 2022 May; 109(5):265-267. PubMed ID: 35856769 [TBL] [Abstract][Full Text] [Related]
6. Effects of dupilumab treatment on patch test reactions: A retrospective evaluation. de Wijs LEM; van der Waa JD; Nijsten T; Silverberg JI; Kunkeler ACM; Hijnen DJ Clin Exp Allergy; 2021 Jul; 51(7):959-967. PubMed ID: 33960047 [No Abstract] [Full Text] [Related]
7. Clinical characteristics and genetic variation in atopic dermatitis patients with and without allergic contact dermatitis. Lee S; Wang HY; Kim E; Hwang HJ; Choi E; Lee H; Choi EH Eur J Dermatol; 2018 Oct; 28(5):637-643. PubMed ID: 30530433 [TBL] [Abstract][Full Text] [Related]
8. Both children and adult patients with difficult-to-treat atopic dermatitis have high prevalences of concomitant allergic contact dermatitis and are frequently polysensitized. Boonstra M; Rustemeyer T; Middelkamp-Hup MA J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1554-1561. PubMed ID: 29578626 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis. Malajian D; Belsito DV J Am Acad Dermatol; 2013 Aug; 69(2):232-7. PubMed ID: 23583066 [TBL] [Abstract][Full Text] [Related]
10. Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients? Napolitano M; Fabbrocini G; Patruno C Contact Dermatitis; 2021 Oct; 85(4):473-474. PubMed ID: 33988858 [No Abstract] [Full Text] [Related]
11. Blocking type 2 inflammation by dupilumab does not control classic (type 1-driven) allergic contact dermatitis in chronic hand eczema. Crepy MN; Nosbaum A; Bensefa-Colas L Contact Dermatitis; 2019 Aug; 81(2):145-147. PubMed ID: 30851059 [No Abstract] [Full Text] [Related]
13. Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study. Bocquel S; Soria A; Raison-Peyron N; Badaoui A; Marcant P; Bara C; Giordano-Labadie F; Amsler E; Milpied B; Delaunay J; Darrigade AS; Pralong P; Boulard C; Ferrier Le Bouedec MC; Tauber M; Pasteur J; Valois A; Le Thuaut A; Crépy MN; Bernier C J Am Acad Dermatol; 2024 Mar; 90(3):512-520. PubMed ID: 37871801 [TBL] [Abstract][Full Text] [Related]
14. A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus Opinion. Chen JK; Jacob SE; Nedorost ST; Hanifin JM; Simpson EL; Boguniewicz M; Watsky KL; Lugo-Somolinos A; Hamann CR; Eberting CL; Silverberg JI; Thyssen JP Dermatitis; 2016; 27(4):186-92. PubMed ID: 27427820 [TBL] [Abstract][Full Text] [Related]
15. Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD) Raffi J; Suresh R; Fishman H; Botto N; Murase JE Int J Womens Dermatol; 2019 Dec; 5(5):308-313. PubMed ID: 31909149 [TBL] [Abstract][Full Text] [Related]
16. Allergic contact dermatitis in atopic individuals: Results of a 30-year retrospective study. Teo Y; McFadden JP; White IR; Lynch M; Banerjee P Contact Dermatitis; 2019 Dec; 81(6):409-416. PubMed ID: 31347185 [TBL] [Abstract][Full Text] [Related]
17. Contact hypersensitivity to Indian standard patch test series correlates with disease severity among children with atopic dermatitis. Handa S; Bhattacharjee R; Thakur V; De D; Mahajan R Indian J Dermatol Venereol Leprol; 2023 [SEASON]; 90(1):46-51. PubMed ID: 37609746 [TBL] [Abstract][Full Text] [Related]
18. Occupational Chronic Contact Dermatitis Successfully Treated with Dupilumab: A Case Series. Slodownik D; Levi A; Lapidoth M; Moshe S Dermatology; 2022; 238(6):1073-1075. PubMed ID: 35462358 [TBL] [Abstract][Full Text] [Related]
19. Allergic contact dermatitis in patients with atopic dermatitis: A clinical study. Sharma AD Indian J Dermatol Venereol Leprol; 2005; 71(2):96-8. PubMed ID: 16394381 [TBL] [Abstract][Full Text] [Related]
20. The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis. Owen JL; Vakharia PP; Silverberg JI Am J Clin Dermatol; 2018 Jun; 19(3):293-302. PubMed ID: 29305764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]